CIK 0001820190 · <br>Emerging growth company
Scilex Holding Co
Sign in to watch- Ticker
- SCLX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 516-4310
- Business address
- 960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
- Former names
- Scilex Holding Company/DE, Vickers Vantage Corp. I
Securities
- SCLX Common Stock Nasdaq
- SCLXW Warrant Nasdaq
- 8-K Event Material agreement · Unregistered share sale
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Material agreement
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 15,965,541 shares at an average $0.83 ($13,215,896)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 14,713,490 shares at an average $1.24 ($18,176,455)
- RW Other RW
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4/A Open-market sale 10% owner sold 20,657,300 shares at an average $0.62 ($12,771,580)
- 4 Insider Changes in Ownership
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure
Page 3 of 38 · 742 filings